Cost Insurance

The Real Cost of GLP-1 Treatment Over 12 Months: What to Expect

If you're considering GLP-1 medication for weight loss, you're probably wondering about the bottom line: what will a full year of treatment actually cost? The answer isn't always straightforward, but understanding the complete financial picture is crucial before you start your journey. Let's break down what you can realistically expect to pay over 12 months, from brand-name options to more affordable alternatives.

Understanding GLP-1 Medication Costs

GLP-1 receptor agonists like semaglutide and tirzepatide have transformed weight management, but they come with a wide range of price points depending on which option you choose.

Brand-Name GLP-1 Medications

The most recognizable names in GLP-1 therapy come with premium pricing:

Over 12 months, brand-name GLP-1 medications without insurance typically cost between $11,600 and $19,140. That's a significant investment that many people simply cannot sustain long-term.

Compounded GLP-1 Medications

Compounded versions of semaglutide and tirzepatide offer the same active ingredients at a fraction of the cost. These are prepared by licensed compounding pharmacies and prescribed by qualified physicians.

Compounded GLP-1 medications typically range from $99 to $399 per month, bringing your 12-month total to approximately $1,200 to $4,800. This represents savings of $7,000 to $14,000 compared to brand-name options.

Insurance Coverage: The Wild Card

Whether your insurance covers GLP-1 medications can dramatically change your out-of-pocket costs.

When Insurance Does Cover GLP-1s

If you're fortunate enough to have coverage, your costs might look like this:

Many insurance plans cover Ozempic and Mounjaro for type 2 diabetes but not for weight loss alone. Wegovy and Zepbound, indicated specifically for weight management, have more limited coverage.

When Insurance Doesn't Cover GLP-1s

The reality for most people seeking GLP-1s for weight loss is that insurance won't cover the medication. Currently, only about 25% of employer-sponsored health plans cover anti-obesity medications. Medicare doesn't cover weight loss medications at all, though it does cover diabetes medications.

This leaves many people paying full retail price or seeking alternatives like compounded medications or telehealth services that offer more affordable options.

Hidden Costs to Consider

The medication itself isn't the only expense when calculating your 12-month investment.

Medical Appointments and Monitoring

Traditional in-person care requires regular visits:

Over 12 months, appointment costs alone can add $900 to $2,400 to your total if you're paying out-of-pocket.

Supplies and Accessories

Most brand-name GLP-1s come as pre-filled pens, but you might need:

These add perhaps $50 to $100 annually, a minor expense but worth noting.

Comparing 12-Month Total Costs

Here's what different scenarios might cost you over a full year:

Traditional brand-name with no insurance: $13,000 to $19,000 for medication, plus $900 to $2,400 for medical visits. Total: $13,900 to $21,400.

Brand-name with good insurance coverage: $300 to $1,800 for medication copays, plus potential copays for visits. Total: $500 to $2,500.

Compounded medication through telehealth: $1,200 to $4,800 for medication with medical oversight included. Total: $1,200 to $4,800.

The difference between the most expensive and most affordable option is over $16,000, which explains why so many people are turning to compounded options and telehealth providers.

Gender Considerations in GLP-1 Costs

While the medication costs themselves don't differ by gender, there are some practical differences worth noting.

Women may require more frequent monitoring during childbearing years, as GLP-1 medications aren't recommended during pregnancy. This could mean additional pregnancy tests and counseling visits. Both women and men may experience different side effects that require management, potentially affecting appointment frequency and additional medication costs for symptom relief.

Women statistically earn less than men on average and are more likely to work part-time, which can affect both insurance coverage and ability to afford out-of-pocket costs. This makes access to affordable GLP-1 options particularly important for women seeking weight management solutions.

Making GLP-1 Treatment Sustainable

The key to successful GLP-1 therapy isn't just starting treatment—it's sustaining it long enough to achieve and maintain your health goals.

Budget for the Long Term

Weight management with GLP-1s typically requires ongoing treatment. Research shows that discontinuing the medication often leads to weight regain. When evaluating costs, think beyond 12 months. Can you afford this for 18 months? Two years? Longer?

Evaluate All Your Options

Don't assume brand-name medications are your only choice. Compounded semaglutide and tirzepatide from reputable providers offer the same active ingredients with proper medical oversight at a fraction of the cost.

Consider Telehealth Services

Telehealth platforms often bundle medication, doctor consultations, and ongoing support into one monthly fee, eliminating surprise costs and simplifying budgeting. This model works especially well for people with busy schedules or limited access to specialists.

From the Ozari Care Team

We understand that cost is often the deciding factor in whether someone can access life-changing GLP-1 therapy. The most important thing is finding a sustainable option that includes proper medical oversight—your safety and success depend on physician guidance, appropriate dosing adjustments, and monitoring for side effects. Cheaper isn't always better if it means cutting corners on medical care, but affordable options with full clinical support do exist.

Finding Affordable GLP-1 Treatment

At Ozari Health, we offer compounded semaglutide and tirzepatide starting at $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026.